1. Medtech Insight
  2. >>Policy & Regulation

US Congress Ends Shutdown, Clinches Two-Year Device-Tax Repeal

 
• By Sue Darcey

Congress reached agreement Jan. 22 to end the three-day US government shutdown in a continuing resolution bill that includes a two-year device-tax suspension.

Capitol House

A two-year delay of the medical device tax was clinched on Jan. 22 after Republican senators struck a compromise agreement with Senate Democrats, gathering sufficient votes to fund the US government until Feb. 8. The bill ends a three-day government shutdown, and also includes a six-year agreement to fund the Children's Health Insurance Program.

Senators voted 81-18 to cut off debate over the continuing resolution bill midday, followed by an 81-18 final vote Monday afternoon to seal the deal. The deal was subsequently approved...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Legislation

More from Policy & Regulation

Inclusive By Design: UK Invites Sponsors To Submit Trial Diversity Plans

 
• By Vibha Sharma

The UK has issued clearer guidance to help drug and medical device sponsors demonstrate how they intend to include a diverse and relevant range of participants in their clinical trials.

Plans For Specific EU Orphan And Pediatric Device Expert Panel Need To Go Further

 
• By Amanda Maxwell

Moves are at last underway for a more specific focus on orphan and pediatric devices. They are a start; but experts are calling for more to support this sector.

First Alzheimer’s Disease Diagnostic Blood Test Cleared By FDA

 
• By Natasha Barrow

Fujirebio Diagnostics' Alzheimer's disease test, Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio, has been cleared by the US FDA.